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Abstract

Parkinson's disease is a chronic neurological disorder aecting hundreds
of thousands of Americans.

The current best practice for assessment of

this disease is a clinical examination and subjective rating using the Unied
Parkinson's Disease Rating Scale. Such ratings are coarse scaled, subject to
rater bias, and costly. Instruments which provide objective measurements
of disease state can eliminate rater bias, provide repeatable data, and increase the frequency and responsiveness of subject assessments, expediting
the validation of new therapies and treatments.
This thesis describes the design and implementation of a battery of
bio-mechanical devices suitable for clinical and in home use, including descriptions of the instruments and the functionality of the data acquisition
software, as well as the overall system used for data collection.

A data

analysis algorithm is fully described, and descriptive statistics of pilot data
from twenty two subjects are reported.
These statistics show promising correlations of time duration metrics
with the motor subsection of the UPDRS, as well as good responsiveness
to dopaminergic intervention. Data also suggests that these devices have an
advantage over previously described devices in the ability to record the full
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range of motion in standard assessment tasks, thereby providing additional
metrics related to hesitations and halts in prescribed movements.
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1 Introduction
1.1 Parkinson's Disease
1.1.1 Denition
Parkinson's disease is a chronic, progressive neurodegenerative disorder aecting
more than 350,000 Americans. The eects of the disease are characterized by prolonged disability and steadily worsening symptoms, although it is not generally in
itself fatal.

1.1.2 Prevalence
Parkinson's disease is the second most common neurodegenerative condition after
Alzhiemers disease [5]. Estimates of total prevalence vary widely, but approximately
50,000 people are diagnosed each year, and between 350,000 and 1,000,000 people
suer from the disease at any given time [2, 4].

Parkinson's is primarily a disease

of the aged-the average onset age is 60 years, with only 5-10% of reported cases
occurring in persons under 40.

It is estimated that 1.6% of persons over the age

of 65 and 2.4% of persons aged 80 to 89 have some form of the disease [35]. The
population over the age of 65 is expected to double by 2040, with a larger portion
of those surviving beyond 85, thus the overall prevalence of Parkinson's disease is
expected to increase as well [3, 5, 6].
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1.1.3 Costs
The duciary cost to individuals is signicant. Persons registered for Medicare pay
an average of 2.5 times the out of pocket costs of other seniors [4], much of this is
in prescription drugs, which average about $2500 a year. Most of the remainder is
due to co-morbidities such as hospitalization due to falls and institutionalization
for dementia or other care needs. With oce visits and incidental costs, the total
outlay due to Parkinson's disease in America is estimated at $5.6 Billion a year.
Costs including lost productivity and unpaid care are estimated at $23-34 Billion a
year [3, 4].

1.1.4 Primary Symptoms of Parkinsonism
Parkinsonism is a general term for the set of symptoms associated with Parkinson's
disease [2].

A number of causes and conditions that present similarly.

The four

cardinal symptoms of Parkinsonism are tremor, rigidity, bradykinesia, and postural
instability.
Parkinsonian tremor is a resting tremor, which becomes more obvious and severe
when the person is resting and improves with intentional movement [1, 2]. Tremor
tends to be present in the hands, arms, legs, jaw and face [1]. Facial tremor usually
involves the jaw, tongue and facial muscles, and not the shaking of the head seen in
essential tremor [2]. Tremor in the hand is typically of the pill rolling type, where
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the thumb and forengers seem to rotate about some point.

Parkinsonian tremor

is generally of fairly low frequency, ranging from 2.5 to 5 Hz [1] and is activated or
increased by stress or emotional excitement. Tremor is typically not present while
sleeping [2].
Rigidity is a sti and weak feeling in the limbs and trunk. Rigidity can manifest
as either a steady lead pipe resistance to movement, which occurs when a person's
muscles remain tense and contracted, or as a cogwheel eect, where resistance to
movement occurs in short, jerky steps. This is caused by the lack of synchronization
between antagonistic muscle pairs [1].
Bradykinesia is a general slowing of movement, sometimes coupled with an inability to initiate movement or akinesia.

In advanced Parkinson's bradykinesia is

subject to rapid uctuations from ease of movement to inability to move, especially
as medication doses wear o [2].
People with Parkinson's suer from postural instability, in the form of impaired
balance and coordination.

This also manifests as a stooped and droopy posture,

as well as halts and freezes while walking [1].

They also have a tendency to lean

backwards or take short backward steps when bumped or starting to walk, an eect
called retropulsion.

People with advanced Parkinson's tend to walk with short,

rapid steps, which is called festination [2].

3

1.1.5 Medications
The biological cause of Parkinson's disease is the death of neural cells in a part of
the brain called the substantia nigra. This portion of the brain produces a neurotransmitter called dopamine, which is essentially the medium by which signals are
passed between neurons. The substantia nigra is the primary dopamine source for
the corpus striatum, which helps regulate movement throughout the body. As the
disease progresses and less dopamine is delivered to the corpus striatum outgoing
signals become unreliable and movements become erratic and uncontrolled.
The primary medication used to treat Parkinson's disease is levodopa. Dopamine
itself is not eective as a medication because it cannot cross the blood-brian barrier,
but levodopa is a dopamine precursor that can do so. It is then metabolized into
dopamine by the enzyme dopa decarboxylase [2] in the substantia nigra.

Because

this enzyme is found throughout the body, very large doses of levodopa would be
required to be eective. To counter this, dopa decarboxylase inhibitors (DDI's) such
as carbidopa or benserazide are given with the levodopa dose. These are peripheral
DDI's, in that they inhibit the metabolization of levodopa in the bloodstream, but
do not aect metabolization in the brain.
In the United States, the most common medication is sinemet, a carbidopa/levodopa
formulation available in various dossages and proportions. As the disease progresses
and neurons in the substantia nigra die, the brain's capacity to metabolize levodopa
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decreases and the medication dose must be increased. This is not a tolerance or loss
of potency of the medication, but an eect of advancing degeneration [1] [2].
These medications can have unwanted side eects. The most noticeable side effect of levodopa is dyskinesia, or uncontrolled, swaying movements.

Large, dance

like movements called choreiform dyskinesias are seen in advanced patients. These
movements typically occur at the peak of a leveodopa dose, although they also occasionally occur at the beginning and end of a medication cycle [1, 2].

Other side

eects can include vivid dreams and nightmares, paranoia, and walking hallucinations. Occasionally these are severe enough to require institutionalization, especially
in patients with reduced mental capacity or severe dementia [2].

1.1.6 Diagnosis
Diagnosis of Parkinson's disease is made clinically based on the person's history
and symptoms. There is no denitive laboratory test for Parkinson's disease. MRI
and CAT scans do not reveal Parkinson's, but can be useful in eliminating alternate diagnosis, such as cerebrovascular disease (stroke) [2], which may present similar symptoms. Radiological imaging devices such as PET and SPECT may reveal
Parkinson's, but cannot necessarily dierentiate Parkinson's from other neurodegenerative conditions.

In addition, the cost and complexity of these devices tends to

limit them to research facilities [7]. Protein aggregates called Lewy bodies are found
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in the brain tissue in Parkinsonian patients. Unfortunately, these can only be seen in
autopsy. Such structures are also found in other diseases such as Multiple Systems
Atrophy(MSA) and Pick's disease.

1.1.7 Assessment
The current best practice for assessment of Parkinson's disease is physical examination by a trained clinician using the Unied Parkinson's Disease Rating Scale
(UPDRS). The clinician assigns scores to forty two items on the UPDRS by physical
examination and verbal inquiry. The scale is divided into four sections: Mentation,
Behavior and Mood; Activities of Daily Living; Motor Examination and Complications of Therapy.
Each section contains a number of items which are rated on a scale of 0 to 5 by
the clinician, with higher numbers correlating to greater severity of symptoms. In
addition a series of yes or no questions are rated as 0 or 1.
Biomechanical assessment devices are concerned primarily with the Motor Examination section.The items in this section deal with physical observables related to
movement speed and muscular control, which are in turn correlated to the cardinal
symptoms of Parkinson's disease.
People with Parkinson's are also rated on the Modied Hoehn and Yahr staging
scale, which rates the general level of impairment on a six step scale, with scores
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increasing as severity increases.

The Schwab and England activities of daily life

is also used to rate subject's independence and ability to perform routine tasks. It
should be noted that this scale is rated from 100 to 0, where 0 is complete helplessness;
i.e. scores decrease with advancing illness.
Parkinson's patients are also often assessed for cognitive impairment, as a number
of items on the UPDRS depend on their ability to understand and respond to specic
queries and instructions.

An example is the Mini Mental State Examination, in

which subjects are rated on a number of questions focusing on orientation, recall
and language ability. This examination is also used to exclude subjects from clinical
trials.
The UPDRS examination is the accepted rating scale for Parkinson's Disease
progression, and in the absence of valid biomarkers, it is the prevailing standard
for diagnosis and assessment of severity.The examination exhibits good intra and
inter-rater reliability, and addresses a variety of symptoms beyond the Physical
motor symptoms. Disadvantages of UPDRS examination include it's coarse rating
scale, which results in in poor responsiveness to changes in disease state, and the
requirement for trained personnel, which complicates blinding in studies, drives up
the cost of clinical practice, and is impractical for home assessment.
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1.2 Problem Statement
As mentioned above, assessment of Parkinson's disease by clinicians using the UPDRS has several disadvantages. The level of training required restricts the number
of raters available, making rating time scarce, and by extension ratings expensive.
The scarcity of clinician time restricts the number of ratings an individual receives,
reducing the number of data points in any assessment of therapy.

It is also not

practical to have clinical raters travel to subjects' homes, which requires subjects to
travel to a clinic for assessment. The stress and activity of such a visit may confound
symptoms and alter performance.

Furthermore, the scarcity of clinician hours for

additional ratings makes it dicult to scale up studies. In general, it is not possible
to suddenly and dramatically increase the number of raters to support a new study.
The reliability of the UPDRS is largely due to its coarse scale and the large number
of symptoms assessed. Assessments of individual symptoms may be subject to rater
bias and subjective scoring.
Biomechanical devices can overcome many of these diculties. Devices could be
issued to subjects, allowing for use at home and at leisure. Assessments could then
be done every day or more, capturing medication cycles and diurnal uctuations.
In the case that large numbers of devices are manufactured for large studies, we
would expect economies of scale and reduced unit costs. Furthermore, mechanical
devices provide objective measures, and need not be blinded to subject identity. To
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achieve this, devices must be reliable, inexpensive, and allow for the possibility of
self administered testing while providing measures that reect the disease state of
the subject.

1.3 Objectives
The objective of this thesis is to demonstrate a biomechanical system which provides
useful metrics for the assessment of the severity of Parkinson's disease, specically
focused on bradykinesia. For the purposes of this thesis, useful will be dened as being responsive to dopaminagenic intervention, specically as distinguishing between
the on and o medication states of a group of subjects to within a certain condence
range. The system will include the electromechanical devices, the analysis algorithms
that provide metrics from raw measurements, and the interface software directs the
testing protocol while collecting and storing data.

1.4 Signicance
The signicance of such a device could include the possible production of a set of
measurements not well described in the literature. Such a device could be suitable
for clinical use, reducing demand on personnel and allowing for greater patient ow.
Such clinical use could provide a standard for the validation of new therapies.
The system will be suitable for clinical trials, again providing a standard for other
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measurements and therapies.

This, combined with faster assessment and greater

patient throughput, could result in faster validation of assessments and interventions.
The system will also be suitable for at home use, allowing for more frequent
assessments and reducing confounding factors.

Again, additional data points and

reduced demand on trained clinicians could expedite validation of treatments and
therapies.

1.5 Demonstration of Mastery
This thesis is intended to demonstrate mastery of knowledge in the eld of Electrical
and Computer Engineering. This demonstration includes the completion of a literature survey to assess the current state of the art in a given discipline, as seen in
chapter 2; the systematic creation of requirements based on use cases, demonstrated
in chapter 3. Signicant contributions were made to the design, implementation and
testing of a device in cooperation with cross-disciplinary colleagues, and the creation
of analysis software, as seen in chapters 4 and
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5 .

2 Existing Technologies & Literature Survey
A number of tests and devices have been described with similar objectives to those
described in chapter 1. In this chapter some of these are discussed for the purpose
of informing the requirements analysis and nal design in subsequent chapters. An
understanding of previous work by other researchers will highlight the advantages of
the devices described in this thesis.

2.1 Instrumented Tests for Quantitative Assessment
2.1.1 Button Tests
Various authors have used button tests to quantify bradykinesia. In it's most basic
form, a pair of buttons are placed approximately shoulder width apart on a table in
front of the subject. When cued to begin, the subject alternately taps each button as
fast as they are able. The button press times are recorded and the rhythmicity and
duration of movement are then computed. Additionally, the subject may be asked
to hold a button down before beginning. The subject is then cued to begin, and the
time between the cue and the release of the button is recorded as reaction time.
The test is advantageous in the simplicity of design and the ease with which
data can be electronically stored. Disadvantages of devices of this type include an
ongoing learning eect [38], as well as being unable to distinguish hesitations or
velocity changes from long duration continuous movements.
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These tests are also

subject to strategies by the test taker, such as a speed versus accuracy tradeo,
where a subject can increase the rate of tapping at the expense of occasionally missing
a button strike.
Giovannoni

et al. [23] attempt to quantify this eect using a keyboard in place of

a button. A target key is dened, and strikes on the target key as well as surrounding
keys are recorded. Strikes on the surrounding keys were recorded as "missed keys"
and used to represent accuracy. They found that the number of missed keys increases
rapidly above a certain threshold rate of keystrikes (described as the Dysmetria
Turning Point). They were then able to create a combined score, but did not nd
correlation with the UPDRS. Ghika

et al. [19] and Ward [28] measured reaction time

and movement time with button devices, and found the movement time of people
with Parkinson's to be signicantly longer than that of age matched controls, while
reaction time was not signicant. Dunnewold,

et al.

[16] also found subjects had a

signicantly lower tap rate than controls.

2.1.2 Finger Tapping Tests
Finger tapping tests in general imitate the twenty-third item on the UPDRS, where
the subject taps the thumb with the index nger in rapid succession.

In general,

more distal movements are more aected by bradykinesia, and have the potential to
provide more responsive metrics. This simple task is also easily learned, and with a
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few moments practice a subject is typically as skilled at the task as they are likely
to get, reducing or eliminating the learning eect. In addition, there are only minor
testing strategies associated with this task, notably a "icking" motion instead of a
clamping tap.
The disadvantage of this task is the diculty of instrumentation. Because of the
"free" posture associated with this movement, devices that attach to the subject tend
to restrict movement. This leads researchers to devices that can detect movement
without contact and at a distance, which tend to be complex and expensive.

In

addition, by restricting measurement to one of the set of 42 items on the UPDRS,
variations in the eect of the disease from subject to subject inevitably reduce the
correlation to the UPDRS as a whole, making it more dicult to establish validity.

2.1.3 Tracking Tests
Tracking tests involve the subject manipulating a device in some way which is not
predictable in advance. The feedback between a changing objective and perception
of current position has been found to be particularly sensitive to disease state. Many
of these tests are computer based, taking advantage of available input devices, as well
as the ease of data storage and change in instructions. Like many of the previously
described tests, tracking tests are often subject to the learning eect and speed versus
accuracy strategies.
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Allen

et al. [20] explored the use of video game peripherals, specically a joystick

and a steering wheel, to implement tracking tests on a computer. Subjects were asked
to use the peripheral input device to follow a moving target on the screen for four
dierent protocols: pseudo random movement, swept frequency, alternating between
xed points, and alternating between xed points with a trigger button. The rst
two are standard tracking tasks, while the second two imitate tapping tests similar
to the button tests mentioned above. They found the best separation between people
with Parkinson's and controls for the xed-point targets.
Montgomery

et al. [40] developed a wrist exion-extension device consisting of a

conical receptical into which the subjects hand is inserted.

The device allows the

subject to ex and extend the wrist, pointing the hand at LED targets arranged in
an arc.

The two rows of LED targets represent the position of the hand and the

target position.

When a target light is lit, the subject moves his hand until the

position LED corresponds to the target.

By recording movement time as well as

target time, reaction time could be computed. By setting targets near to but not
on the end of the target row, overshoot could be measured.

By setting targets in

pseudo-random patterns, subject tracking ability could be tested. They did not nd
this test in itself to be particularly responsive to early stage Parkinson's disease,
although combined with olfactory and mood-mentation tests the combined result
was statistically signicant.
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2.1.4 Purdue Pegboard Test
The Purdue pegboard test was developed in 1948 as a dexterity test for personnel
selection [10], but has emerged as a sensitive assessment of Parkinson's disease [11].
In the standardized version of the test, a board with two vertical rows of 25 holes
each is placed on a table before the subject. On either side of the rows of holes are
cups containing 25 pegs. The subject is instructed to place as many pegs in holes in
30 seconds as possible, rst with the right hand, then with the left, then with both
hands simultaneously. Some versions of the test have an additional "assembly" task,
where washers and caps are placed on the pegs [9].
The test exhibits good to excellent test-retest reliability [9, 10] and very good
correlation to the UPDRS, but poor distinction between symptoms. Pegboard scores
suer with advancing bradykinesia as well as tremor. In addition, a learning eect
has been reported since the test's inception, and like the button test above, the test is
subject to speed versus accuracy strategies. Researchers have also noted a dierence
in performance between men and women and between education levels [10].
Despite these drawbacks, Haaxma

et al. [11] found the pegboard to be a responsive

and reliable instrument, and was in fact by itself as sensitive as the combination of
concurrently given tapping, writing and walking tests.
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2.1.5 Repetitive Alternating Finger Tapping Tests
Another tapping tasks that has been described in the literature is Repetitive Alternating Finger Tapping (RAFT). In this test the subject taps two ngers alternately
as fast as possible, typically on a MIDI piano keyboard or similar device. Having
recorded the duration and timing of keystrikes, the rate, rythmicity and velocity can
then be computed. In some cases metronome-like audio cues are provided and the
subject's ability to follow the provided rhythm is tested.
The dened MIDI standard records keystrike start and stop times which are then
encoded as velocity and duration, as well as allowing for variable sample rates. Equipment is commercially available and data is digitized instantly. MIDI keyboards do
not record a full range of movement; the position of the key is detected by an encoder with limited resolution.

This allows for velocity computation and detection

of key release, but the small physical displacement may or may not be accurately
represented.
Bronte-Stewert

et al.

[34] instructed subjects to repetitively tap two adjacent

keys with the index and middle ngers for 60 seconds, as fast and as regularly
as they could.

The subjects were blindfolded and white noise headphones were

placed over their ears to remove visual and audible feedback.

The velocity and

duration of keystrikes and the interval between them was recorded, and the means
and coecients of variation computed for each. The keystrikes were also examined
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for signs of fatigue, freezing, and failure to alternate between keys.

They found

that while controls were able to maintain the alternating keystrikes for the full 60
seconds, Parkinsonian subjects' performance began to degrade after as little as 10
seconds. They also found occasional sections of high frequency (i.e greater than 4
Hz) non-alternating tapping that could be classied as tremor.
Koop

et al.

[22] instructed subjects to repetitively tap two adjacent keys with

the index and middle ngers for 30 seconds.

The velocity of the keystrikes was

then recorded and the mean velocity computed. They found that the mean velocity separated control subjects from early PD subjects, and that nger and forearm
bradykinesia could be detected by this method in subjects who had not yet developed postural velocity symptoms, as seen in concurrent dynamic posturography
measurements.
Tavares

et al. [33] performed a similar test on subjects before and after bilateral

subthalamic nucleus deep brain stimulation (B STN DBS), a neurosurgical procedure
involving electrical stimulation of the subthalamic nucleus, which can be eective in
controlling severe symptoms [2]. Subjects again tap two adjacent keys for 30 seconds.
In this case the mean velocity, duration of nger strike and interval between strikes
were computed for each nger. The coecient of variation was then computed for
each of these measures. They found that the combination of mean velocity, mean
duration, and coecient of variation of duration showed the highest correlation to the
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UPDRS motor section. Furthermore, both dopaminergic medication and B STN DBS
improved the velocity of, and interval between, keystrikes, while duration, coecient
of variation of duration, and coecient of variation of interval improved more with
B STN DBS than with medication.

2.1.6 Spiral Tracing Tasks
A common test for the assessment of tremor and dyskinesia is the tracing over a
spiral printed on a piece of paper.

With the advent of digital tablets, this test

became popular due to the immediate digitization of data, as well as tasks and
testing protocols that can be controlled in software, making them relatively easy to
adjust.

The digital tablet is relatively inexpensive and intuitive to use, making it

ideal for at-home studies.
The primary disadvantage of tablets is the limited movements they can record.
They are essentially restricted to movements of the hand and wrist, in two dimensions, making it very dicult to imitate existing items on the UPDRS.
Liu

et al.l [15] used a digital tablet to analyze round and square spirals, traced by

subjects suering from dyskinesia induced by levodopa. They were able to correlate
measurements derived from the spiral trace to UPDRS dyskinesia scores, although
they did not observe a dierence between square and round spirals.
Ide

et al. [18] added a tracking task consisting of a screen display with a marker
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indicating the position of the pen on the tablet, and a target to which the subject
is to move the pen.

As the target moves and the subject attempts to follow it,

the positions of the target and pen are recorded, and metrics such as reaction time,
position error, and pen velocity are extracted. They found signicant dierences in
subjects before and after deep brain stimulation.

2.2 Other Instrumentation
2.2.1 Electromagnetic Detection
Various schemes have been implemented for electromagnetic detection of position,
which would then be combined with UPDRS tasks for quantication. The attraction
of such a system is the freedom of movement which would allow for a variety of
tasks. It is reasonable to believe that the reduction in repeatability with unrestricted
movement would be oset by the additional tasks available.
Kandori

et al.

[12] constructed such a device to measure position during a grip-

and-release task, a test used by surgeons to diagnose myelopathic symptoms in a
patient's hands. The system consists of a 20 kHz oscillator feeding a transmit coil
mounted on the wrist and ve detection coils mounted on four ngers and the forearm. When energized by the magnetic eld produced by the oscillator, the detector
coils produce a voltage which is amplied and compared to the 20 kHz oscillator
signal using a phase detector. The resulting phase dierence is low pass ltered and
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output to analog to digital converter for digital storage and analysis.
Healthy volunteers axed the device to their dominant hand and gripped a 30 cm
reference rod. They were then asked to open and close their hands as fast as they
were able to for 15 seconds, repeating for the non-dominant hand. Although they
were able to detect specic events (i.e. the opening and closing of the hand), Kandori

et al.

were not able to provide direct position information due to the non-linearity

of the detected voltage.
The 3Space Fastrack (Polhemus, Colchester, VT) is a commercial electromagnetic
tracking device that has been used to quantify amplitude and speed impairment, as
well as tremor. The Fastrack has a centralized transmitter and up to four passive
sensors. The sensors contain orthogonal coils detecting the AC magnetic eld produced by the transmitter. The device then computes position and orientation with
six degrees of freedom in real time. The stated range of the device is 4-6 feet, with
a static position and angular accuracy of .0015" and .15 degrees.
Espay

et al.

[13] axed sensors to subjects' thumb and forenger while they

performed a tapping task, then to the forenger and jaw for a nger-to-chin task.
This study was designed around the dissociation of speed and amplitude metrics,
and they found that amplitude was more aected by medication state than speed.
They further found amplitude measurements to correlate more strongly to UPDRS
ratings, while speed measurements were more closely related to timed tests, notably
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the Purdue Pegboard and tapping tests.
Spyers-Ashby

et al. [14] used the same device to quantify tremor, in an eort to

distinguish between Parkinson's disease, essential tremor and multiple sclerosis. In
this case the sensor was axed to the dorsal face of the hand and subjects were
seated in a straight backed chair with their arm extended.

By analysis of time

domain position data they were able to distinguish between normal subjects and
patients and multiple sclerosis patients from Parkinson's patients very well, but it
was more dicult to distinguish between subjects with Parkinson's and those with
essential tremor.

2.2.2 Accelerometry
Accelerometers have been used extensively by many researchers. The small size and
passive nature (i.e. no specic movement is required for data) make them ideal for
assessment of movement disorders. Accelerometric data can be taken concurrently
with other tests such as button tests or the UPDRS. In addition, accelerometric data
can be taken continuously, allowing for a broader assessment of motor function than
is possible with discrete, snapshot tests.
Disadvantages of these devices include the relatively complex signal processing required to extract meaningful measurements. Furthermore, continuous measurements
require continuous power and data storage, increasing the complexity and cost of the
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electronic system.
Dunnewold

et al. [16] used two and three axis accelerometers in conjunction with

a button test, and found two axes sucient for the assessment of bradykinesia. They
also show that resting tremor did not adversely aect their assessment. Sherrill

et

al. [26] axed nine accelerometers to subjects while they performed a set of UPDRS
tasks.

Motor UPDRS and dyskinesia were then assessed by video review.

They

report a correlation between features extracted from the accelerometric data and
clinicians assessments.
Meyers

et al. [29], axed a uniaxial accelerometer to the index nger while surface

electromyography (EMG) leads were axed to the extensor digitorum and rst dorsal
interosseous muscles on the same nger. Subjects performed a tapping task where
they tap the instrumented nger while attempting to synchronize to an intermittent
tone with a constant rhythm, they are then asked to continue tapping at the same
pace after the tone stops.

The test was repeated on and o medication.

They

report accelerometric measurements being more sensitive to medication than the
EMG signal, although both could distinguish between on and o states. In addition,
they found that variability in movements tend to change over time, with internally
cued movements being much more variable than those cued by the external pace
tone.
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2.2.3 Video Motion Capture
Video motion capture can be used in conjunction with a variety of motor tasks,
including nger movements such as tapping tests, as well as larger movements such
as arm pronation/supination or walking gait. In general, a set of passive reective
markers are placed on the subject at points where movement is to be tracked. An
infrared light source and a set of orthogonally oriented cameras with selective lters
are then used to record the movement of the markers. By knowing the initial position
of the markers with respect to the cameras, the movements can then be reconstructed
as data, and computations performed.
The disadvantage of such systems is that they are generally large, expensive,
and not practical for at home or continuous use. The signal processing involved in
reconstructing movements can also be complex and dicult.
Agostino

et al. [32] used a three dimensional infrared system to measure kinematic

performance of subjects instructed to tap their index nger against their thumb for
three ve-second trials, then each of their ngers in turn against their thumb, again
for three ve-second trials. The motion of the nger was recorded and the number of
taps, the amplitudes of extension and exion, the durations of exion and extension,
and the pause between were computed.

They found that people with Parkinson's

had lower amplitudes and longer pauses than controls, and that their performance
decreased more rapidly with additional trials.
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Jobbagy [39] assembled a system using infrared markers and a consumer-grade
video camera.

Subjects placed their hands in prescribed positions in front of the

camera and tapped each nger in turn in a pianolike movement, lifting each nger
as rapidly and as high as they can.

The position of each nger is recorded and

a Finger Tapping Test Score (FTTS) is composed of amplitude, frequency and
periodicity is then computed. They show that the FTTS is lower in subjects with
Parkinson's disease than in controls, and that subjects with Parkinson's often have
substantial dierences between right and left hands.

2.2.4 Mounted Transducers
A more direct way to capture movement is to record position directly with mechanical movement transducers.

Devices using potentiometers and encoders mechani-

cally coupled directly to the subject can be used to record the full range of simple
movements with great accuracy and resolution. Advantages of such systems include
relatively simple signal processing and low cost, intuitive devices.
The primary disadvantage of such systems is the diculty of mechanically monitoring a movement without interfering with or restricting said movement.
Sauermann

et al. [17] used a hand held thumb trigger with a resistive transducer

to measure the rate and position of thumb tapping. By measuring the full range of
motion, they were also able to directly quantify periods of hesitation or freezing, a
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bradykinetic eect that would otherwise only be seen as a component of the overall
rate of tapping. They found good correlation with the 25th item on the UDPRS,
hand pronation/supination.

The time spent in hesitation also correlated with the

hand opening and closing score, UPDRS 24.
Andria

et al. [27] measured the force applied by a palmer grip.

The device consists

of a palm-rest and nger handle, instrumented with force cells. Subjects were cued
by an audio tone to begin squeezing the handle as hard as possible for 6 seconds, at
which time a tone was played to cue them to stop. The rise time, fall time , and total
force applied were then computed. They found that the total force and the fall time
were most relevant in dierentiating between people with Parkinson's and controls.
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3 Development of Requirements
3.1 Applications
3.1.1 Clinical Trial Use
To develop goals and requirements, two distinct applications are considered.

The

rst case is use in clinical trials to assist in validating new therapies where a clinician
currently assesses the subject using the UPDRS. The objective in the short term is
to provide a metric to augment the UPDRS, and in the long term to replace it all
together with quantitative assessments.
The clinical trial case requirements are in some sense the most urgent, as participation in clinical trials would be part of the process to validate any device developed.
Trials conducted in clinic allow the possibility of assistance and instructions for the
subject, and the centralized location reduces the need for a mass-producible device.
The physical and mechanical design must be such that it is well tolerated by clinicians and subjects. Complicated or hard to use devices are less desirable to those
actually administrating the study, physical discomfort or restriction of movement is
likely to reduce subject participation.
Clinical trials involving at-home use have additional requirements.

The advan-

tages of a self administered test taken at home include additional data points which
may capture daily or medication cycle uctuations and the reduction of travel and
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clinical visit related confounders mentioned in Section

1.3. An at home test would

be repeated by the same subject many times with no assistance or supervision, which
requires the possibility of self administration. This implies a lack of dicult straps,
tments, or restraints. Any cues or instructions must be pre-recorded or automated,
and data must be recorded and reported automatically. Such devices must also be
sized in such a way that subjects can reasonably be expected to accommodate them
in their homes, and be portable enough to be shipped. Bringing the devices to subjects rather than subjects to centralized devices also implies that many more devices
would be needed, requiring a manufacturable and inexpensive design.

3.1.2 Clinical Therapy Use
The second case is day-to-day clinical practice. A quantitative device could be provided to a clinician who would use it in standard assessment of disease progress. This
would in general imply a greater number of subjects using the device regularly.
The design requirements for this case include all those mentioned above in clinical
trials, with the additional requirement that such devices must be fully and convincingly validated as providing measures of the progression of the disease. The ease of
use criteria also becomes more important in this case, as clinicians are unlikely to
incorporate a new device into their practice if the inconvenience of use outweighs the
benet, and subjects are less likely to regularly use such a device at home.
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3.2 Other Requirements
In addition to the requirements specic to application, a set of general goals apply
to all devices, specically balancing the conicting goals of test repeatability versus
subject comfort and minimization of the learning eect.

3.2.1 Enforcement of Repeatability
For repeatability, it is desirable for a subject to take a test the same way each time,
as should multiple subjects taking the same test.

Variation can be introduced by

subject conditions such as fatigue and learning, as well as test taking strategies which
may be employed.
One design concept employed to reduce variability is that of enforced compliance,
or designing devices in such a way that there is only one way to take a test, so that
each subject wants to do it in the same way. This is dicult in practice, as nearly
all biomechanical test devices are subject to some form of strategy.
In many cases, compliance can be enforced and strategies reduced by constraining
the subjects movement in some way. Although this can reduce variability, there are
disadvantages to this approach. The primary disadvantage is subjects and clinicians
in general do not like it. Subjects respond negatively to being strapped in in any
way, especially if they are unable to extricate themselves under their own power.
Clinicians prefer not to have complicated devices that require extra training for
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administrators and extra set up time for subjects.

3.2.2 Repression of the Learning Eect
To reduce the learning eect, tests should be designed to be learned as fast as
possible, and subjects should be allowed to practice using any new device before
data is taken. This can most easily be accomplished by simple, repetitive movements.
Movements that are a part of everyday tasks are also desirable, on the grounds that
subjects have already practiced these tasks on a day to day basis. Caution should
be taken to avoid assuming uniform prociency across populations however. Certain
subpopulations, such as pianists or ten key operators, may exhibit greater abilities
at tasks resembling their vocations.

3.3 Summary of Requirements
All of the requirements above are considered in the process of developing new devices.
It is quite possible, however that not all of them can be realized in the short term.
Furthermore, qualitative goals such as convenience and reduction of strategies can be
satised to varying degrees. The design goals and requirements are assigned priorities
in Table 1. Each priority is rated on a scale of 1 to 5, where 5 is absolutely required
for any degree of success, 4 is greatly desired, and others are prioritized in numerical
order.
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Goal

Priority

Tolerance by subject

5

Convenience of use for clinician

5

Minimization of learning eect

4

Minimization of strategies

4

Minimal restriction of movement

3

No attachment to subject

4

Can be self administered (mechanically)

4

Can be self administered (software)

3

Automatic data upload (software)

3

Portable

2

Can be accommodated in home

3

Mechanically robust

2

Manufacturable Design

2

Low cost design

1

Table 1: Summary of prioritized goals and requirements.
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4 Design
This chapter provides technical descriptions and design justications for the devices
in the Biomedical Signal Processing (BSP) lab at PSU, with which pilot data was
collected at the Movement Disorders Clinic at the Oregon Health Sciences University
(OHSU) neurology department. This includes the trigger-type nger tapper and the
foot tapper, as well as the software, protocol, PC and data acquisition device used
to collect the data in chapter
PC are described in Section

6. The biomechanical devices, data acquisition, and
4.1. The set of tests and instructions are referred to

collectively as the Protocol, described in Section

5.2, while the MATLAB script

that provides instructions and records data is referred to as the Data Acquisition
Software, described in Section

4.2.

analysis software, described in Section
Figure

The data collected is analyzed by the data
4.3.

1 below describes the overall layout of the system. Each biomechanical

device is tted with a quadrature encoder, the output of which is read into the
Labjack U6 data acquisition device, which streams data to a notebook computer via
USB interface. An executable generated in MATLAB then saves the streamed data
to a le while populating an on-screen display.
This MATLAB script also provides on-screen instructions to the subject and administrator, including printed text, audio and video content. During the paced tapping test, an audio le with metronome tapping cues is played.
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This audio le is

split between headphones worn by the subject and an analog input on the Labjack,
which records the audio synchronously with the position data from the quadrature
encoder.

Figure 1: Signal diagram for complete system.

4.1 Hardware
Both devices are designed to measure the full range of motion required for a tapping
task with minimal restriction of the subject's movement, while at the same time
enforcing compliance to reduce variability. The nger tapping device is designed to
allow tapping of the end of the index nger against the second knuckle of the thumb,
a task that is considered to be more sensitive to early stage Parkinson's than the
traditional ngertip to thumbtip tapping prescribed by the UPDRS. This nger-toknuckle tapping is referred to as as OHSU tapping, and nger-to-thumbtip tapping
as "UPDRS" tapping.

The single nger task closely imitates the UPDRS while
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eliminating strategies evident in some keyboard tasks.
The foot tapping device measures the angle of the foot as the toes are tapped,
rotating on the heel. This involves considerably less movement than the UPDRS leg
agility item. It is possible that the more distal location of the movement may prove
to be more responsive.
As mentioned above, these tapping devices can provide eectively continuous
feedback to the subject, if desired. This makes the devices more intuitive and user
friendly by allowing the subject to see how their movements aect measurements,
while at the same time providing simple and instant verication that the device is
working properly. Furthermore, visual feedback allows for possible future studies to
implement tracking tasks, if desired.

4.1.1 Finger Tapper
The nger tapping device consists of an aluminum baseplate with a steel shaft, or
mast, centered at about three quarters of the length. The mast supports an aluminum
crossbar, or boom, which in turn supports the two encoder enclosures, which hang
down over the baseplate. Hanging from the bottom of the encoder enclosures are the
hand grips, thumbrest and manipulandum. The height of the boom on the mast is
adjustable by a quick release pressure clamp. The angles of the encoder enclosures
on the boom are also adjustable, being held in place by pressure t rubber washers.
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Figure 2 shows the assembled device, and Figures 3 and 8 show the device in use.

Figure 2: Finger tapping device with parts labeled.

The handgrip is made of wood and aluminum and features a guard to separate
the other ngers from the index nger during tapping tests. The thumbrest is made
of plastic and mounts on the top of the handgrip.

The stationary position of the

thumb enforces nger-to-thumb tapping, reducing variations due to test strategies.
Figure

4 below is a detailed image of the hand grip and encoder assembly.

The mainupulandum consists of a narrow steel jib protruding from the encoder
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Figure 3: Finger tapping device showing subject arm position.

enclosure and ending in a small plastic bucket, or cap, for the nger tip. The cap has
an aperture to accommodate large ngernails. The proximal end of the manipulandum jib connects to an axle supported by bearings on either side. The axle functions
as the encoder shaft; the manipulandum jib forms a lever arm to rotate the encoder.
A light spring returns the manipulandum to a starting position approximately 90
degrees from the thumbrest.

4.1.2 Foot Tapper
The foot tapping device consists of an aluminum base plate with a heel stop and
two sets of brackets, each with an aluminum swing arm. The two swing arms are
connected by a steel crossbar. An aperture is cut into the baseplate, and the crossbar
is bent in such a way that it extends into the aperture when the crossbar is fully
depressed. A light spring returns the crossbar and swing arms to their resting position
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Figure 4: Detail of nger tapping device hand grip and encoder assembly.

at about 90 degrees o the baseplate. One of the swing arms is attached to a rotary
encoder shaft mounted in a bearing just above the baseplate. The swing arm serves
as a lever arm to rotate the encoder.

Figure

6 below shows the assembled foot

tapper with parts labeled.
The baseplate features screw down spikes to hold it in position on carpet. Grip
tape and a curved heel rest reduce foot movement while tapping, and rubber pads
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Figure 5: Finger tapping device handgrip showing subject hand position.

prevent the swing arms from hitting the base plate, reducing noise and subject feedback.

4.1.3 Transducers
The angular position transducers are identical for both devices. Each device is tted
with a HEDM-5600 J06 rotary incremental quadrature encoder (Avago Technologies,
San Jose CA) with a resolution of 1024 steps per revolution, or about .35 degrees per
step. There are no stops on the encoder, allowing unlimited full rotations and the
absence of mechanical contact within the encoder reduces wear on the transducer.
The encoder wheel is mounted on a shaft which is supported by a bearing system
designed for the purpose of reducing the resistance to movement and required torque.
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Figure 6: Foot tapping device with parts labeled.

The quadrature encoder provides position data with predictable quantization
noise, predictable power draw and minimal EMI at the expense of additional signal processing.

The quadrature must either be decoded with additional hardware

or read as two digital streams and decoded in software.

We have chosen a data

acquisition module that decodes quadrature and passes it to the PC via USB.
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4.1.4 Data Acquisition Module
The encoder interfaces with the PC through an external data acquisition system,
the LabJack U6 (LabJack Corporation, Lakewood CO), sampling at 10 kHz. This
device has two on-board timers allowing it to perform quadrature decoding of the
two pulse channels from the encoder. The LabJack is also used to capture the audio
clicks used to cue the subject to tap at specic rates.

Position and audio data is

then sent to the PC as three 16 bit packets: LSB, Audio, MSB.

4.1.5 Notebook Computer
The PC used to capture data from the LabJack is an Acer Aspire 1 (Acer Inc., Taipei
Hsien, Taiwan).

This notebook PC has a small footprint, is inexpensive, and has

built in wireless capability. The operating system is Windows XP.
The PC provides instructions to the administrator and subject, as well as cues
for paced tapping, as described in the protocol below. A second monitor is provided
for the subject display, including video instructions and visual feedback for practice
sessions. Audio cues are taken from the PC headphone jack and split between an
analog input on the Labjack and the subject display and headphones.

The audio

cues are re-recorded by the data acquisition system to account for unknown latency
and DAC rates in the Aspire's built in sound bus.
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4.1.6 Headphones
Headphones are provided to provide pacing cues to the subject while reducing feedback during the paced tapping test, both due to the noise of the device and unconscious cues from the administrator. The headphones have the additional advantage
of restricting the metronome pacing to the subject, which reduces disturbance to the
clinical environment.

4.2 Data Acquisition Software & Graphical User Interface
The graphical user interface provides step-by-step instructions to the administrator
to insure that the test is uniformly administered across subjects. The list of steps is
referred to as the test protocol, described in Section 5.2. Each item of the protocol
is represented by a radio button running down the side of the screen. Each button
is described in detail below.

4.2.1 Opening Screen
Figure

7 is a screen capture from the opening screen.

The opening screen provides instructions to the administrator to record subject
information. The specic information recorded and the entry methods are listed in
Table

2 below.
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Figure 7: Data acquisition software opening screen

Information

Entry Method Options

Enter the subject ID

Text Entry Box

Select the device ID

Pull Down Box

(not applicable)
'Finger Tapper' or 'Foot Tapper'

Select the side that will be tested

Pull Down Box

'right', 'left' or 'NA'

Select the most aected side

Pull Down Box

'right', 'left' or 'NA'

Select the medication state

Pull Down Box

'on', 'o ' or 'NA'

Select the dominant side

Pull Down Box

'right', 'left', 'Both' or 'NA'

Table 2: Subject information interface.

This screen also instructs the administrator to "Ready the video recorder" and
then "Continue to UPDRS video".

After entering the subject's information, the

administrator selects the "UPDRS 1 Video" radio button, which opens the next
screen.
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4.2.2 UPDRS 1
Selecting the "UPDRS 1 Video" radio button causes a video instruction to play in
windows media player on the subject display. In the case of the nger tapper, the
video instructs the subject to tap ngertip to thumbtip.

In the case of the foot

tapper, they are instructed to stomp their foot on the ground as high and as fast
as possible.

The administrator then records the activity with a video camera for

later rating. After the video nishes, the subject display shows position display and
the velocity bar, while the administrator display instructs them to continue after
recording.

4.2.3 UPDRS 2
Selecting the "UPDRS 2 Video" radio button causes another video instruction to play
in windows media player on the subject display. In this case, if the current device
is the nger tapper, the subject is instructed to tap the ngertip against the rst
knuckle of the nger. If the current device is the foot tapper, the subject is instructed
to tap their toes on the ground as fast and as big as possible. The administrator then
records the task with a video camera for later rating. With the exception of slightly
dierent tasks in the instructional videos, this step is the same as the previous one.
After the video nishes, the subject display shows position display and velocity bar,
while the administrator display instructs them to continue after recording.
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4.2.4 Fitting the Device
Selecting the "Fitting the Device" radio button causes a video instruction on the
physical use of the device, either nger tapper or foot tapper, to play in windows
media player on the subject display. Figure 8 below shows a capture from the nger
tapper instructional video.

Figure 8: Capture from Finger Tapper instructional video shown during "Fitting the Device".

While the video is playing, the subject learns to operate the device, assisted the
administrator if necessary. The administrator display instructs the administrator to
continue to the next step after the subject is comfortable and has proper command of
the device. After the video is completed, the subject display returns to the position
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display and velocity bar.

4.2.5 Initialize Position
Selecting the "Initialize Position" radio button brings up instructions on the administrator display to click the reset button after having the subject fully depress the
manipulandum. While "Initialize Position" is selected, the reset button causes the
current position of the manipulandum to be set to zero and all future positions to
be measured with respect to that point. If the radio button is not selected, the reset
button does not have this eect. The administrator display instructs them to select
Practice with Bar when they are ready to continue to the next step.

4.2.6 Practice with the Bar
Selecting the "Practice w/ Bar" radio button causes a video instruction specic to
the foot or nger tapper to play on the subject display. This video instructs them
to tap as large and as fast as possible to raise the velocity bar.

After the video,

the subject display shows the velocity bar with instructions to try to make it go
as high as possible. The administrator display instructs them to continue when the
subject has nished practicing. Figure 9 below shows a capture from the foot tapper
practice instructional video.
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Figure 9: Capture from foot tapper practice video shown during "Practice With the Bar".

4.2.7 "Fastest" Instructions
Selecting the "Practice with the Bar" radio button causes an audio instruction on the
fast tapping test to play. The Subject display shows the velocity bar and Fastest
instructions. The administrator display instructs them to select Test: 3 Trials and
press the start button when the subject is ready to continue.

4.2.8 3 Trials Fast Test
The three trials fast test consists of three ten second trials during which the subject
is asked to tap as high and as fast as possible.
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Between each trial the subject is

shown their score in taps per minute and allowed to rest for ten seconds. The angular position data for each trial is stored as a ".mat" le. Table 3 below summarizes
the audio and text cues displayed to the subject during the test.

Time
0
10
.

Audio Cue

Subject Display

start

(Velocity Bar)

Take a rest before

Rest (10 Second rest timer)

the next round"

Your score is N taps per minute

.

for the 1rst trial.Try and do better!

.
20

three. . . two. . . one. . . Start!

(Velocity Bar)

30

Take a rest before the

Rest (10 Second rest timer)

next round"
.

Your score is N taps per minute

.

for the 2nd trial. Try and do better!

.
40

three. . . two. . . one. . . Start!

(Velocity Bar)
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You have completed the test.

Your score is N taps per
minute for the 3rd trial. 
You have completed the test.

Table 3: Subject Cues for 3 Trials Fast Test.

Selecting the "Test: 3 Trials" radio button causes the subject display to show only
the velocity bar, while the administrator display instructs them to press the start
button to begin the test. When the start button is pressed, data recording begins, a
ten second timer appears on the administrator screen, and an audio le plays. The
audio le cues the subject to begin tapping, and then to rest after ten seconds. At
this time a 10 second "rest" timer appears on the subject screen, and the subject
is shown their score as Your score is N taps per minute for the rst trial. Try and
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do better!.

At the end of the ten second rest period, an audio cue counts down

as three. . . two. . . one. . .

Start! and another ten second trial begins. This repeats

until the subject has completed three trials, after which the subject display shows
the additional message You have completed the test. The administrator display
shows scores from all trials during the entire test.

At this time the administrator

display instructs them to Select Headphones on when they are ready to continue.

4.2.9 Headphones On
Selecting the "Headphones On" radio button causes a video instructing the subject
to put on the headphones to play on the subject display. The administrator display
instructs them to assist with headphones and proceed to paced instructions.

4.2.10

Paced Instructions

Selecting the "Paced Instructions" radio button causes a video instruction for the
paced tapping test to play on the subject display. The video instructs the subject
to tap along to the recorded beat and to continue tapping after the beat fades, as
described in section

4.2.11, below.

The administrator display instructs them to

select Test: Paced Taps and press the start button when they are ready to begin.
The data from this test is not considered in this thesis.
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4.2.11 Paced Tapping Test
The paced tapping test consists of six consecutive trials, each separated by a ten
second rest. Each trial consists of a paced portion, where a metronome pacing cue is
provided to the headphones, and an un-paced portion, where pacing cue stops and
the subject attempts to continue to tap at the previously provided pace. With each
trial, the rate of tapping is increased; the tapping frequencies are 1.5 Hz (taps per
second), 2 Hz, 2.5 Hz 3 Hz, 3.5 Hz and 4 Hz. This test is taken with the head phones
on and the eyes closed to reduce the feedback to the subject, as they are to tap based
only on internal control if possible. Playing the audio cues in headphones reduces
the possibility of involuntary, sympathetic tapping by the administrator, as well as
reducing disturbances to the clinical environment. As mentioned in 4.2.10, the data
from this test is not considered in this thesis.

4.2.12 Repeat Paced Tapping Test
Selecting the "Repeat Paced Taps" radio button repeats the paced tapping test
exactly as previously described.

At the end of the test, a video instructing the

subject to remove their headphones plays on the subject display. The paced tapping
test was not repeated for the subjects whose data is analyzed in this thesis due to
time constraints, but may be repeated in future studies.
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4.2.13 Repeat UPDRS 1 & 2
Selecting the "UPDRS 1 Video" and "UPDRS 2 Video" radio buttons have exactly
the same response as above in sections 5.3.2 and 5.3.3.

The purpose is to cause

oine raters to rate the same subject in the same state twice, so as to establish
intra-rater reliability.

The tapping video was not repeated for the subjects whose

data is analyzed in this thesis due to time constraints, but may be repeated in future
studies.

4.2.14 Switch Devices
Selecting the "Switch Devices" radio button causes the subject display to show a
blank screen. The administrator display instructs them to select the other device ID
and repeat the protocol steps. The administrator must physically unplug the current
device (either nger or foot tapper) and connect the other one. They then return to
the UPDRS1 Video button and repeat the protocol from there with the other device.

4.2.15 Upload Video
Selecting the "Upload Video" radio button causes Windows explorer to open the
ATB Data directory.

The administrator then connects the video camera used for

UPDRS recordings and drags all of the .avi les into this directory. This is typically
the last step before clicking on the "close" button.
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4.2.16 The "Close" Button
When the Close button is pressed, all data and video les are zipped and saved.
If the software can nd an internet connection, the data is uploaded to BSP lab
data servers for oine processing. The data is also saved locally on the PC used to
administer the test.

4.3 Data Analysis Software
The data analysis can be divided into three discrete tasks:

Populating the Data

Structure, Data Analysis, and Statistical Comparison. In general terms, the Populating the Data Structure step assembles position data from multiple channels within
a trial and then assembles and data structure from multiple trials. The Data Analysis step computes metrics for each trial within the data structure, and the Statistical
Comparison step analyses metrics and test conditions for correlations. Each step is
considered separately in the sections below.

4.3.1

Populating the Data Structure

The rst step in analysis is to combine the .mat les from all of the subject's trials
in to a single data structure for analysis as conceptualized in Figure

10 below. As

this is a fairly computationally intense process, the resulting data le is saved and
reloaded for later analysis, and updated only when new subject data is available.
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Figure 10: Block diagram of data structure population.

Each subject takes the 3 Trials Fast test once with each device in the o medication
state, then repeats it in the on state. Each trial produces a .mat le, resulting in
12 les per subject all together.
detailed in Table

Each .mat le is a data structure with 13 elds,

4.

Field

Description

annotations

String assigned in the Protocol GUI by the test administrator

subjectID

Subject's identity number

data

Data recorded by Labjack, stored as one vector interleaved

testDate

Number representing the time and date that data was saved

sideTested

String assigned in protocol - 'right', 'left' or 'NA'

mostAectedSide

String assigned in protocol - 'right', 'left' or 'NA'

medicationState

String assigned in protocol - 'on', 'o ' or 'NA'

dominantSide

String assigned in protocol - 'right', 'left', 'Both' or 'NA'

testTag

String assigned by protocol software:
'3 Trials: Fast w PTFB' or 'Paced Tapping'

nTrial

Number of trial in 3 trials test

testDuration

Duration of data recording in seconds

scanRate

Sample rate per channel, set to 10 kHz

num_channels

Number of channels interleaved in stream
Table 4: Data Fields in Unprocessed .mat Files.

A MATLAB script is written which loads each of the .mat les from a target
directory structure and creates a data structure with the elds in Table
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5. With

the exception of the angle eld, the value in each eld is directly assigned from a
eld in the raw structure. The angle eld consists of a vector constructed from the
data eld in the raw structure, which in turn consists of three channels interleaved.
The rst sample represents the least signicant bits of the position decoded from
the quadrature streams by the LabJack, the second is a sample of the audio track
from the analog in channel of the Labjack, the third is the most signicant bits of
the decoded position. The MATLAB script assembles the least and most signicant
values. The result is then decimated to a sample rate of 1000 Hz and written to the
angle eld in the data structure.

Field

Description

sampleRate

Sample rate after down-sampling, set to 1000 Hz

angle

Vector of position data

frequencies

Vector of nominal cue frequencies for paced tapping

tPrompts

Vector cue times for paced tapping

deviceName

String assigned in protocol - 'ngerTapper' or 'footTapper'

iSubject

Subject's identity number

annotations

String assigned in the Protocol GUI by the test administrator

sideMostAected

String assigned in protocol - 'right', 'left' or 'NA'

dateNumber

Number representing the time and date that data was saved

motorState

String assigned in protocol - 'on', 'o ' or 'NA'

cTrial

Number of trial in 3 trials test

duration

Duration of data recording in seconds

testSummary

String assigned by protocol software - '
'3 Trials: Fast w PTFB' or 'Paced Tapping

sampleRateFactor

Sample Rate Factor

Table 5: Data Structure Fields Assigned Directly.
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4.3.2 Data Processing
After a data structure is assembled from all the trials, another MATLAB script processes the three trials data to obtain metrics for comparison with test conditions.
Although Paced Tapping data is present in the data structure, this thesis considers
only the three trials test. The Data Processing step can be further subdivided into
two tasks- sorting and event detection.

Sorting
If the data structure exists, it is loaded, otherwise it must be populated as above.
A four column matrix is constructed based on the motorState and testSummary
elds, where the data structure indexes of 'on' '3 Trials: Fast w PTFB' trials are
placed in the rst column, 'o ' '3 Trials: Fast w PTFB' in the second.

'On' and

'Paced Tapping' trial numbers are placed in the third column, 'O ' and 'Paced Tapping' in the fourth.

The resulting matrix is referred to as the "Address Matrix".

The analysis in this thesis will be on the rst two columns of the address matrix, '3
Trials: Fast w PTFB' in the on and o motor states.

Event Detection
The concept of an "event" is dened in the most general sense as any set of
samples comprising a region of interest.

To nd events, a median lter is applied
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angular position data to atten peaks and troughs, and regions with greater than 10
consecutive identical samples are dened as "events". The events are then classied
as described in Table

6. The numbers of the starting and ending samples of all of

the events in a given trial are collected as a vector and appended to the trial's entry
in the data structure.

Each event in this vector in turn has a substructure which

includes elds such as amplitude, duration, and classication. The complete set of
elds are tabulated in Table 7.

Event
Peak

Description
An event with an amplitude higher than it's
previous and subsequent neighbors

Trough

An event with an amplitude lower than it's

Left Saddle

An event with an amplitude higher than it's

Right Saddle

An event with an amplitude lower than it's

previous and subsequent neighbors
previous and lower than it's subsequent neighbors
previous and higher than it's subsequent neighbors
High Trough

A subset of troughs with an amplitude within one
standard deviation of the mean peak amplitude

True Trough

A subset of troughs with an amplitude within two
standard deviations of the mean trough amplitude

Indeterminate

An event which does not meet any of the previous criteria
Table 6: Descriptions of event classications.

Events are classied as peaks, troughs, right saddles or left saddles based on
their amplitudes in degrees with respect to their nearest neighbors. Figures 11 and
12 are plots of angular position with detected events highlighted.

Red events are

peaks, green are troughs, blue are left saddles, olive are right saddles, and purple are
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indeterminate.

Figure 12:

Detail from the same trial showing

Figure 11: Plot of a subject trial with detected trough, left saddle, peak and right saddle.
events highlighted.

The duration of each tap is computed as the period between each "true" trough,
where true troughs are those below a threshold angle dened as two standard deviations of the mean trough amplitude, as seen in Figure

12. The number of taps

is computed as the number of true troughs detected. Cycle amplitude is computed
for each peak as the dierence between peak and adjacent trough angles, again illustrated in Figure 12. Mean and standard deviations of amplitudes and tap durations
are computed and appended to each trial's entry in the main data structure, as are
the number of taps and duration of each event classication in samples. Table 8 below shows the complete set of computed elds. These elds will be used to compute
the various metrics in Section

5.3.1.

55

Field

Description

startTime

Starting time of event, in samples

amplitude

Angle of event, in degrees

eventNumber

Chronological number of event

endTime

Ending time of event, in samples

length

Elapsed time of event, in samples

previousAmp

Angle of previous event, in degrees

previousLength

Elapsed time of previous event, in samples

previousEnd

Ending time of previous event, in samples

nextAmp

Angle of next event, in degrees

nextLength

Elapsed time of next event, in samples

nextEnd

Ending time of next event, in samples

peak

Boolean 1 if event is a peak, 0 otherwise

trough

Boolean 1 if event is a trough, 0 otherwise

rightSaddle

Boolean 1 if event is a right saddle, 0 otherwise

leftSaddle

Boolean 1 if event is a left saddle, 0 otherwise

troughPeriod

Duration between this event, if a trough,
and the next trough, in samples

eventTime

Sample at which event is considered to have occurred
Table 7: "eventStructures" Substructure Fields.

Field

Description

events

Vector of starting and ending times of
detected events

meanTroughPeriod

Mean of durations between troughs

stdTroughPeriod

Standard Deviation of durations between troughs

troughPeriods

Vector of durations between troughs

numberOfTaps

Number of thresholded troughs

eventStructures

Substructure of detected events

cycleAmplitudes

Vector of cycle amplitudes

meanCycleAmplitudes

Mean of cycle amplitudes

stdCycleAmplitudes

Standard deviation of cycle amplitudes

totalPeakTime

Total duration of "peak" events, in samples

totalTroughTime

Total duration of Trough" events, in samples

totalRightSaddleTime

Total duration of "RightSaddle" events

totalLeftSaddleTime

Total duration of "LeftSaddle" events

totalIndeterminateEvntTime

Total duration of events not otherwise classied

totalHighTroughTime

Total duration of "HighTrough" events

Table 8: Data Structure Fields Assigned to Trials in Data Processing.
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5 Methodology
5.1 Subjects
Subjects were recruited from the Movement Disorders Clinic at the Oregon Health
Sciences University (OHSU) neurology department. Subjects were between the ages
of 50 and 80 and have conrmed diagnosis of Parkinson's disease, as well as demonstrated responsiveness to levodopa. For inclusion in the study, subjects had to be able
to stand and walk unassisted and follow verbal instructions. Subjects with medical
or psychiatric conditions that prevent safe testing or operation of the devices were
excluded, as were subjects with medical conditions other than Parkinson's disease
which result in signicant impairment of movement.
When tested, subjects arrived at the test site in the morning after withholding
their medication for at least 12 hours.

The o medication state was veried by

a clinician and a UPDRS rating was performed.

The subjects performed the the

protocol as described in Table 9, along with some additional tests for related studies.
Subjects performed the test on their most aected side. After completing the tests,
they took an extra large dose (about 120% of their usual dose) of levodopa and
waited one hour. The subjects were then re-examined by the clinician to verify an
on medication state, and a new UPDRS was performed. The subjects then repeated
the test batteries.
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5.1.1 Motor UPDRS
The metrics discussed in Section

5.3.1 are compared for correlation to the motor

subsection of the UPDRS, which consists of 27 items directly related to movement.
These items include assessments of rigidity, tremor, slowness of movement, gait and
facial expression. Assessments were provided by the clinical research assistants who
administered the protocol, and are not blinded.

5.2 Protocol
The protocol is delineated by the data acquisition software, as described in Section
4.2, and provides step by step instructions to the administrator and subject. The
protocol steps are summarized in Table

9.

Protocol Item

Purpose

1

Subject information is recorded

Provides the test conditions

2

Video of UPDRS tapping (nger tapper)

Tapping is recorded for verication

Video of leg agility (foot tapper)

.

3

Video of OHSU tapping (nger tapper)

.

Video of toe tapping (foot tapper)

.

4

Fitting the device

Insures the basic operation of the device

5

Initialize position

Begin tap at 0 degrees for ease of analysis

6

Practice for three trials fast test

Helps to reduce the learning eect

7

Three trials fast test

Tests amplitude, maximum rate of

8

Paced tapping Test

Tests the eect of the loss of pacing tones

9

Repeat for other device

Each item is done with the nger

tapping and hesitations and halts

tapper and foot tapper
Table 9: Protocol steps for each device.
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Each of these items is intended to be executed in order, although items may be
restarted or repeated at the discretion of the administrator. The interface provides
an annotation eld in which any irregularities can be noted. This section describes
the intentions and relevance of the protocol items, while the actual execution of each
is described in Section

4.2.

5.2.1 Subject Information
The subject's tested side, most aected side, dominant side, and medication state
are recorded. These will be used to establish the conditions for the data set. The
subject ID and device ID (i.e Finger Tapper or Foot Tapper) were also assigned at
this point, as certain parameters in the data acquisition software are dierent for
each device.

5.2.2 Video Recording
A video recording of the tapping task was made to serve as a check on subject's
performance, and to conrm the operation of the devices. The eld of view of all
video recordings was limited to hands or feet to prevent subject identication.

5.2.3 Three Trials Fast Test
The Three Trials Fast test consists of three ten second trials during which the subject
is asked to tap as large and as fast as possible.
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Between each trial the subject is

allowed to rest for ten seconds.

The data collected is angular position data, and

metrics are computed as described in Section

4.3.2. The repetition of three simple

tasks allows us to estimate repeatability and helps to suppress the learning eect.

5.2.4 Paced Tapping Test
The paced tapping test consists of six consecutive paced trials, each separated by
a ten-second rest, as described in Section

4.2. The data recorded is angular posi-

tion, as well as raw audio recordings of the pacing cues. The audio is re-recorded
synchronously with the position data to avoid unknown or ambiguous latencies in
the playback and sampling, particularly as the software is compiled to a standalone
executable from MATLAB. The data from this test is not considered in this thesis.

5.3 Metrics
For the purpose of this section, the word
to a condition to assess symptoms.
medication state and device.

metric refers to a quantity which is compared

The word

condition

refers to the combined

All of the metrics described are derived from the

measured quantity of angular position, and each is associated with a condition. For
convenience, metrics are subdivided into two broad categories: amplitude and period
metrics and event duration metrics. Each of these is described in detail in the relevant
section below.
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5.3.1 Amplitude and Period Metrics
The amplitude and period metrics consist of the mean trough period, standard deviation of trough period, mean cycle amplitude, standard deviation of cycle amplitude,
and the number of taps. These are listed in Table

10. Each of these quantities was

computed and appended to the data structure in Section

4.3.2. The mean trough

period represents the average period between valid troughs for one trial of the three
trials fast task, and the standard deviation is the standard deviation of the same set
of periods. Cycle amplitude is computed as the dierence in angular position value
between each peak and adjacent trough, the mean and standard deviation of the set
of amplitudes within a trial is computed in the same manner as above. The number
of taps represents the number of times the subject completes full tapping motion,
and is computed by counting the number of valid troughs detected.

Metric
mean of trough period
standard deviation of trough period
mean of cycle amplitude
standard deviation of cycle amplitude
number of taps
Table 10: List of amplitude and period metrics.

5.3.2 Event Duration Metrics
The event duration metrics consist of the total peak time, total trough time, total
right saddle time, total high trough time, and total indeterminate event time. These
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are tabulated in Table 11. Each metric is reported in samples. The total time elapsed
for each type of event was computed and appended to the data structure in Section
4.3.2.

Metric
total peak time
total trough time
total right saddle time
total high trough time
total indeterminate event time
Table 11: List of event duration metrics.

5.4 Conditions
For each metric, the average of all three trials for each condition was computed for
each subject. This resulted in a score (an average of means or average of standard
deviations) for each subject, which was then plotted versus the motor UPDRS scores
assigned by the clinician. Correlation coecients were then computed between the
two. This was repeated for each condition in Table 12.

Abscissa

Ordinate

motor UPDRS

Finger Tapper On Score

motor UPDRS

Finger Tapper On Score

motor UPDRS

Foot Tapper O Score

motor UPDRS

Foot Tapper O Score

Table 12: Conditions plotted for each metric.
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5.5 Correlation Coecients
The amplitude, period and event duration metrics are compared to UPDRS rating
scores using the built in MATLAB function

corrcoef,

which produces a matrix of

correlation coecients. The correlation coecient is an indicator of the amount of
variation in one variable that can be explained by variation in another.

It varies

from -1 to 1, with -1 and 1 indicating a strong linear relationship and zero indicating
no relationship. A general interpretation is that coecients with an absolute value
below .3 indicate a weak relationship, and coecients above .7 indicate a strong
relationship, assuming there is sucient data to estimate the correlation.

5.6 Eect Size
To examine the relation to medication state, the eect size is computed. For each
metric, the mean and standard deviation of the value of the metric for three trials
is computed for both the on and o medication states.

The eect size

d

is then

computed as:

d=

Where

µoff

trials, and

µoff − µon
1
(σoff + σon )
2

is the mean of o medication trials,

σoff

and

σon

µon

is the mean of on medication

are the standard deviations of o and on medication trials,

respectively.
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Eect size can be interpreted as a measure of how well the instruments can distinguish between the on and o medication states. If the two conditions both have
low variance and widely separated means, a large eect size is obtained.

As the

variance of either condition increases, it becomes more dicult to distinguish between conditions, and eect size decreases.

Practically speaking, most eect sizes

are less than one, although there is no theoretical limit on the value.
size as computed for this thesis is similar to Cohen's

The eect

standardized mean dierence

with pooled deviation. Cohen's rule of thumb for interpretation is that eect sizes
below .2 are "small" eects, those over .8 "large" eects, and those in between are
"medium", with the caveat that dierent disciplines and dierent data types might
have dierent thresholds for description [41].
Eect size and dierence of means are reported in Table
period metrics and Table

17 for event duration metrics.
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15 for amplitude and

6 Results & Discussion
6.1 Data
6.1.1 Group Statistics
Subject data were provided to the BSP laboratory identied only by subject number.
Subject data sets were excluded at the discretion of the lab if instructions were not
followed satisfactorily, devices failed or data was corrupted. Twenty two subjects are
included in the analysis. No age or gender information was provided. Handedness
is established by the clinician by inquiry. Subject responses are tabulated in Table
13, below.

Information

Right Left Both

Dominant Side

20

1

1

Most aected side

16

6

0

Tested side

14

8

0

Table 13: Number of subject responses.

Five subjects reported being right hand dominant and left side most aected,
these subjects were tested on the left side. The single left handed subject reported
the left side to be most aected.
The data analysis described produced 11 metrics in four conditions, producing
44 plots. The eect size for each metric for the nger and foot tapper produced an
additional 22. As it is not immediately clear which if any are useful for assessment,
coecients are generated automatically for inspection, and tabulated in Tables
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14,

15, 16 and 17. Metrics with correlation coecients greater than .3 are examined in
Chapter

6.2.

6.1.2 Amplitude and Period Metric Data
The four conditions in Table

12 are computed for each of the ve metrics in Table

10. Correlation coecients with respect to the motor UPDRS are reported in Table
14, and eect sizes in Table

15. Select plots are presented in Chapter 6.2.

Metric

Device Med State p value Correlation

Mean trough period

Finger

on

0.607

0.113

Mean trough period

Foot

on

0.547

-0.132

Mean trough period

Finger

o

0.979

0.006

Mean trough period

Foot

o

0.108

-0.344

St.Dev. trough period

Finger

on

0.459

0.163

St.Dev. trough period

Foot

on

0.534

0.137

St.Dev. trough period

Finger

o

0.111

0.341

St.Dev. trough period

Foot

o

0.248

-0.251

Mean cycle amplitude

Finger

on

0.777

-0.062

Mean cycle amplitude

Foot

on

0.456

-0.164

Mean cycle amplitude

Finger

o

0.152

-0.309

Mean cycle amplitude

Foot

o

0.121

-0.333

St.Dev. cycle amplitude

Finger

on

0.312

0.220

St.Dev. cycle amplitude

Foot

on

0.217

0.268

St.Dev. cycle amplitude

Finger

o

0.128

0.327

St.Dev. cycle amplitude

Foot

o

0.212

0.271

Number of taps

Finger

on

0.591

-0.118

Number of taps

Foot

on

0.509

0.145

Number of taps

Finger

o

0.537

0.136

Number of taps

Foot

o

0.178

0.291

Table 14: Correlation coecients for amplitude and period metrics.
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Metric

Device Eect Size

Mean trough period

Finger

Mean trough period

Foot

0.422

St.Dev. trough period

Finger

1.128

0.843

St.Dev. trough period

Foot

Mean cycle amplitudes

Finger

-0.520

0.221

Mean cycle amplitudes

Foot

-0.699

St.Dev. cycle amplitudes

Finger

0.320

St.Dev. cycle amplitudes

Foot

0.065

Number of taps

Finger

-0.757

Number of taps

Foot

-0.577

Table 15: On versus o eect size for amplitude and period metrics.

6.1.3 Event Duration Metric Data
The four conditions in Table

12 are computed for each of the six metrics in Table

11. Correlation coecients with respect to the motor UPDRS are reported in Table
16, and eect sizes in Table

17. Select plots are presented in Chapter 6.2.
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Metric

Device Med State p value Correlation

Total peak time

Finger

on

0.804

-0.055

Total peak time

Foot

on

0.486

0.153

Total peak time

Finger

o

0.421

0.176

Total peak time

Foot

o

0.094

0.357

Total trough time

Finger

on

0.808

-0.054

Total trough time

Foot

on

0.569

0.125

Total trough time

Finger

o

0.287

0.232

Total trough time

Foot

o

0.316

0.219

Total right saddle time

Finger

on

0.941

0.016

Total right saddle time

Foot

on

0.714

0.081

Total right saddle time

Finger

o

0.625

0.108

Total right saddle time

Foot

o

0.412

-0.180

Total left saddle time

Finger

on

0.961

-0.011

Total left saddle time

Foot

on

0.704

0.084

Total left saddle time

Finger

o

0.132

-0.324

Total left saddle time

Foot

o

0.009

0.535

Total high trough time

Finger

on

0.278

-0.236

Total high trough time

Foot

on

0.137

0.319

Total high trough time

Finger

o

0.245

-0.252

Total high trough time

Foot

o

0.481

-0.155

Total indeterminate event time

Finger

on

0.044

-0.424

Total indeterminate event time

Foot

on

0.108

0.344

Total indeterminate event time

Finger

o

0.157

-0.305

Total indeterminate event time

Foot

o

0.814

-0.052

Table 16: Correlation coecients for event duration metrics.

Metric

Device Eect Size

Total peak time

Finger

Total peak time

Foot

-0.286

Total trough time

Finger

-0.106

Total trough time

Foot

Total right saddle time

Finger

-0.079

Total right saddle time

Foot

-0.095

Total left saddle time

Finger

0.678

Total left saddle time

Foot

0.066

Total high trough time

Finger

Total high trough time

Foot

Total indeterminate event time

Finger

0.053

Total indeterminate event time

Foot

0.216

0.067

0.588

0.014
-0.458

Table 17: On versus o eect size of event duration metrics.
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6.2 Discussion
6.2.1 Clinical Notes and Test Irregularities
In addition to the annotations eld on the data structure, clinicians were encouraged
to provide notes on test sessions when they found this to be appropriate. A selection
relevant to data exclusion and overall design are presented here.

Subjects were

identied by subject ID numbers assigned by the test administrators. Subjects were
numbered 212 through 237.

•

Subjects were tested on the side they reported as most aected, with the exception of subjects 221 and 224.

Subject 224 tested on the left side after an

unspecied failure of the right nger tapper, no explanation for subject 221
testing on the less aected side is available.

•

The nger cap on the nger tapper came loose during subject 223's o state
testing. The cap was repaired and the test was repeated.After inspection of the
data, the subject was included in the analysis.

•

Subject 230 did not receive a UPDRS rating in the o state, and is therefore
excluded.

•

The software crashed during subject 235's tapping test.

As it was unclear

exactly how to include a partial data set, the subject was excluded.
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•

Subject 236 apparently dozed o during the tapping test.

As it was unclear

exactly how to account for this, the subject was excluded.

•

The encoder apparently failed during one of subject 237's tapping tests. As it
was unclear exactly how to include a partial data set, the subject was excluded.

•

Of the 264 trials analyzed, 78 had average trough amplitudes over 100 degrees,
implying they either experienced an odd software malfunction, or more likely
the position was not initialized. Trials inspected visually had no other obvious
irregularities, and consecutive trials were consistently oset. As the detection
algorithm is robust to the oset, the trials were included. This aects 6 of 22
subjects.

6.2.2 Amplitude, Period, and Event Duration Metrics
The computation of the Mean Trough Period, Standard Deviation of Trough Period,
Mean Cycle Amplitude, Standard Deviation of Cycle Amplitude, and Number of
Taps is discussed in Section

5.3.1. Other researchers have found metrics related to

rates of tapping [16] [33] [39] and amplitude of tapping [32] to correlate with the
UPDRS. The UPDRS rating of the nger tapping task is based on a number of
subjective criteria, including rate, amplitude, regularity and so forth. The analysis
presented here considers only individual measurements in isolation. A more sophisticated analysis could combine the best metrics to produce a better assessment.
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Table 18 shows all metrics with correlation coecients over 0.3. The four highest
correlations in the data presented are event duration metrics, associated with hesitations halts, or episodes of freezing. Left saddle time appears twice in the top four.
This sort of feature would occur on the way up during a tapping task, suggesting
hesitation. Figure 14 shows a time domain plot of a subject with an obvious hesitation at about 5.5 seconds. Note that the nger rests against the thumb at the lowest
angle, in this case -80 degrees, where small hesitations are visible throughout. Plots
of the left saddle means with respect to motor UPDRS are seen in Figures 15 and 20.
The presence of indeterminate event time as the metric with the second highest
UPDRS correlation is surprising. Plots of this metric versus motor UPDRS are seen
in Figures 16 and 19. It was originally included in the analysis mainly as a check on
the event detection algorithm, and represents events not otherwise classied by the
detection algorithm. Although these events are unclassied, an inspection of their
occurrence suggests they are not entirely irrelevant to bradykinesia. The rst and last
events in a trial are by nature indeterminate, thus a large indeterminate score may
indicate slow start, or inability to initialize movement. The second condition that
produces an indeterminate detection is two events of the same amplitude, separated
by a movement that does not trigger an event detection, as seen in Figure 13. An
example might be a subject holding their foot down and twitching slightly, then
returning to the same position. An excursion of less than 10 ms would not trigger a
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peak detection. This type of movement might again be associated with inability to
eciently initiate movement, hesitation or even tremor.

Figure 13:

Detail of a trial showing a "split"

trough, detected as indeterminate.

Figure 14: Detail of a trial showing numerous hesitations and halts.

The best amplitude or duration metric is mean trough period, seen in Figure
18. The fact that it occurs with the foot tapper is encouraging, as foot tapping is
underrepresented in the literature.

Metric

Device Motor State p Value Correlation

Total left saddle time

Foot

o

0.009

0.535

Total indeterminate event time

Finger

on

0.044

-0.424

Total peak time

Foot

o

0.094

0.357

Total left saddle time

Finger

o

0.132

-0.324

Mean trough period

Foot

o

0.108

-0.344

Total indeterminate event time

Foot

on

0.108

0.344

std trough period

Finger

o

0.111

0.341

Mean cycle amplitude

Foot

o

0.121

-0.333

std cycle amplitude

Finger

o

0.128

0.327

Mean cycle amplitude

Finger

o

0.152

-0.309

Total indeterminate event time

Finger

o

0.157

-0.305

Table 18: Event duration and period metrics with highest correlation coecients.
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footTapper off

fingerTapper on

250

700

totalIndeterminateEvntTime

totalLeftSaddleTime

Correlation Coefficient: 0.535
200

150

100

50

0
20

30

40

50

60

500
400
300
200
100
0
10

70

Correlation Coefficient: −0.424

600

20

Motor UPDRS

30

40

50

60

Motor UPDRS

Figure 15: Plot of the correlation of left saddle Figure 16: Plot of the correlation of indeterminate
time with respect to motor UPDRS.

event time with respect to motor UPDRS

footTapper off

footTapper off

1200

0.55

Correlation Coefficient: 0.357

1000
900
800
700
600
500
20

Correlation Coefficient: −0.344

0.5

meanTroughPeriod

totalPeakTime

1100

0.45
0.4
0.35
0.3
0.25

30

40

50

60

0.2
20

70

Motor UPDRS

30

40

50

60

70

Motor UPDRS

Figure 17: Plot of the correlation of total peak Figure 18: Plot of the correlation of mean trough
time with respect to motor UPDRS.

period with respect to motor UPDRS.
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footTapper on

fingerTapper off
250

Correlation Coefficient: 0.344

1200

Correlation Coefficient: −0.324
totalLeftSaddleTime

totalIndeterminateEvntTime

1400

1000
800
600
400

200
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100

50

200
0
10

20

30

40

50

0
20

60

Motor UPDRS
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40

50

60

70

Motor UPDRS

Figure 19: Plot of the correlation of indeterminate Figure 20: Plot of the correlation of left saddle
event time with respect to motor UPDRS.

time with respect to motor UPDRS
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6.2.3 Eect Sizes
To nd the relationship between metrics and medication state, the computation and
interpretation of eect size is described in Section

5.6.The equation for Cohen's

d

is repeated here for convenience:

d=

µoff − µon
1
(σoff + σon )
2

All of the eect sizes over .3 are reported in Table

19, below. The level of .3 is

chosen to exclude small eects.

Metric

Device

std trough period

nger tapper

Eect Size

mean trough period

nger tapper

0.843

number of taps

nger tapper

-0.757

mean cycle amplitudes

foot tapper

-0.699

total left saddle time

nger tapper

total trough time

foot tapper

0.588

number of taps

foot tapper

-0.577

mean cycle amplitudes

nger tapper

-0.520

total high trough time

foot tapper

-0.458

std cycle amplitudes

nger tapper

1.128

0.678

0.320

Table 19: Eect size metrics with highest mean eect size.

The rst notable thing about these values is the very large eect size of the leading
metric. The mean eect size for the nger tapper standard deviation of trough period
is greater than 1, indicating a strong eect. It also appears in Table

18. Although

the correlation of .341 is not spectacular, it is the seventh highest presented here.
This metric is similar to the variation in tapping examined by the button tests in
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Section

2.1.1 and repetitive nger tapping in Section

2.1.5.

Since this has been

shown to be eective by other researchers, it is not surprising that it is among the
best metrics.
In contrast to the correlation values in Table 18, four of the top ve values in this
table are nger tapper metrics, and none of the top four is an event duration metric.
This is disappointing in that the eect size and UPDRS correlation do not seem
to reinforce one another, with the exception of total left saddle time which appears
on both tables. Mean cycle amplitude, standard deviation of cycle amplitude also
appear on both Table

18 and Table

19, but UPDRS correlation coecients are

small for both.
A histogram of the eect size of the standard deviation of trough period for the
nger tapper is plotted in Figure
all subjects.

21.

The vertical line shows the mean value of

A mean that is shifted away from zero indicates a strong eect, and

a preponderance of subjects on one side of zero supports that statement.

In this

case there are outliers present which probably shift the mean unduly to the right,
but the bulk of subjects are on the same side of zero. This plot supports continued
investigation of this metric.
Figure

22 shows a histogram of the eect size on mean trough period for the

nger tapper. The vertical line is again the mean value of eect size for all trials.
In this case the mean is shifted, and the bulk of the distribution is to the right of
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fingerTapper

fingerTapper
12

12
10

10

StDev: 2.175

Subjects

Subjects

StDev: 3.396

8

8
6

6

4

4

2

2

0
−2

Mean: 0.843

Mean: 1.128

0

2
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6

8

0
−10

10

−5

0

5

10

Effect Size− meanTroughPeriod

Effect Size− stdTroughPeriod

Figure 21: Plot of the eect size of trough period Figure 22: Plot of the eect size of mean trough
period.

standard deviation.

zero. Figures 23 and 24 are eect size histograms for number of taps and mean cycle
amplitudes. The plot of the foot tapper in Figure 23 appears to be grouped around
zero, with the mean shifted slightly negative. The outlier at ten is an unusually large
eect size. The foot tapper in Figure 24 appears to have the mean shifted in to the
left by negative outliers, and once again has a peak around zero.
fingerTapper
10

footTapper
7

Mean: −0.757

Mean: −0.699

6
StDev: 3.647

8

StDev: 2.419

Subjects

Subjects

5
6

4

4
3
2

2
1
0
−10

−5

0

5

10

0
−8

15

Effect Size− numberOfTaps

−6

−4

−2

0

2

4

Effect Size− meanCycleAmplitudes

Figure 23: Plot of the eect size of the total num- Figure 24: Plot of the eect size of mean cycle
ber of taps.

amplitudes.
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7 Summary & Conclusion
7.1 Summary
In this thesis two biomechanical devices were developed for the assessment of Parkinsonian bradykinesia. A literature survey was conducted on the state of the art of
disease assessment, and requirements were developed. Durable prototypes were built
and pilot data was collected in a clinical environment. Software was developed to
administer tests and collect data. Algorithms and software were created to analyze
data. The author is directly responsible for conduct of the literature survey, prototyping of several preliminary devices, specication and sourcing of all encoders and
related materials, and design and implementation of data analysis software.
This thesis describes the design of the devices and the functionality of the data
acquisition software, as well as the overall system used for data collection. A data
analysis algorithm is fully described, and descriptive statistics of pilot data are reported. These statistics show promising correlations of time duration metrics with
the motor subsection of the UPDRS, as well as good responsiveness to dopaminergic
intervention.
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7.2 Conclusion
The high eect size of the nger tapper standard deviation of trough periods makes
it a promising metric in terms of dierentiation between medication states. Although
correlation with the UPDRS is not high for any metrics, the results for event duration
metrics were encouraging, suggesting that there might be a value in assessing halts
and freezing. This, in turn, supports the measurement of full range of movement in
assessment of Parkinsonian symptoms.
The devices described in this thesis are capable of making the same measurements
examined by other researchers with button tests and nger tapping tests, with the
addition of measuring the full range of motion.

The resulting time duration met-

rics cannot be obtained from previously described devices such as keyboard nger
tappers, button tests or pegboard tests. Furthermore, unlike full motion detection
systems, these devices are inexpensive and suitable for use in the home.
The metric analysis does not clearly support either the nger or foot tapper
to be signicantly more responsive than the other.

This supports their continued

deployment as a battery, and possible future combination of metrics.

7.3 Avenues for Further Research
The devices presented in this thesis are part of an ongoing eort in the Biomedical
Signal Processing Laboratory to develop a battery of test devices to augment and
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eventually replace the motor UPDRS. Due to the continuous nature of the design
process, changes have already taken place that partially outdate the information
presented here.

•

The data analysis software is undergoing steady improvement. The detection
algorithm could be improved to classify indeterminate events and provide better
partial tap metrics, which might provide better assessments of hesitation and
freezing.

•

More powerful statistical methods will be introduced to form combinatorial metrics which might better separate medication states and have better correlation
to the motor UPDRS.

•

Updated prototype mechanical devices are being fabricated. Experiments with
the manipulandum and nger cup on the nger tapper are ongoing.

Future

versions will be less restrictive and allow for measurement of both OHSU and
UPDRS tapping. The next version of the foot tapper includes a goniometer/legbrace which standardizes the angle of the subject's leg, and may increase the
repeatability of the device.

•

The data acquisition software has been updated with a more pleasing appearance and a simpler controls. The automatic upload of data to a data server is
near completion.
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•

It is hoped that the data presented here will be augmented by analysis of additional data sets produced during the same clinical sessions. The value of the
standard deviation metric in this thesis suggests that tests focused on pacing
and variation in rate of tapping will likely be valuable.
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